摘要
目的探讨依达拉奉注射液在颅脑外伤中的治疗作用。方法将50例颅脑外伤患者随机分为两组,治疗组在对照组常规治疗的基础上加用依达拉奉注射液30mg,每日2次,连用21天;两组分别于治疗前及治疗后21天进行神经功能缺损程度评分与疗效评定。结果治疗21天后,治疗组神经功能缺损评分为(9.6±6.3)分,低于对照组的(14.4±7.6)分(P<0.05),治疗组的显效率和总有效率分别为44.0%和68.0%,高于对照组的32.0%和52.0%(P<0.05)。结论依达拉奉治疗颅脑损伤疗效确切,有重要的临床应用价值。
Objective To evaluate the clinical effect of edaravone in the treatment of craniocerebral injury. Methods 50 paitents were randomly divided into 2 groups. The control group reeived routine therapy. Besides the same therapy, the treated group was given with edaravone 30rag biw day for 21 days. Necurological functional deficit scores and the efficacy were assessed. Results After 21 days the treated group's scores (9,6±6.3) was lower than the control group scores (14.4±7.6) (P〈0.05). There was also difference between the two groups in apparent effect rate and inprovement rate (P〈0.05). Conclusions Edarovone is an effective in the treatment of cranioncerebral injury.
出处
《海南医学》
CAS
2006年第10期20-21,共2页
Hainan Medical Journal